SK282132B6 - Farmaceutická tableta a spôsob jej výroby - Google Patents

Farmaceutická tableta a spôsob jej výroby Download PDF

Info

Publication number
SK282132B6
SK282132B6 SK956-98A SK95698A SK282132B6 SK 282132 B6 SK282132 B6 SK 282132B6 SK 95698 A SK95698 A SK 95698A SK 282132 B6 SK282132 B6 SK 282132B6
Authority
SK
Slovakia
Prior art keywords
famciclovir
tablet
pharmaceutical tablet
weight
lactose
Prior art date
Application number
SK956-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK95698A3 (en
Inventor
Michael John Greenway
Jennifer Mary Slater
Original Assignee
Novartis International Pharmaceutical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd. filed Critical Novartis International Pharmaceutical Ltd.
Publication of SK95698A3 publication Critical patent/SK95698A3/sk
Publication of SK282132B6 publication Critical patent/SK282132B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK956-98A 1996-01-16 1997-01-13 Farmaceutická tableta a spôsob jej výroby SK282132B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals
PCT/EP1997/000195 WO1997025990A1 (fr) 1996-01-16 1997-01-13 Comprimes a dose elevee de famciclovir

Publications (2)

Publication Number Publication Date
SK95698A3 SK95698A3 (en) 1999-01-11
SK282132B6 true SK282132B6 (sk) 2001-11-06

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
SK956-98A SK282132B6 (sk) 1996-01-16 1997-01-13 Farmaceutická tableta a spôsob jej výroby

Country Status (38)

Country Link
US (1) US6765007B1 (fr)
EP (1) EP0874632B1 (fr)
JP (2) JP4711360B2 (fr)
KR (1) KR100338829B1 (fr)
CN (1) CN1132582C (fr)
AP (2) AP747A (fr)
AR (1) AR005456A1 (fr)
AT (1) ATE220910T1 (fr)
AU (1) AU713090B2 (fr)
BG (1) BG63488B1 (fr)
BR (1) BR9706982A (fr)
CY (1) CY2390B1 (fr)
CZ (1) CZ287205B6 (fr)
DE (1) DE69714215T2 (fr)
DK (1) DK0874632T3 (fr)
DZ (1) DZ2159A1 (fr)
EA (1) EA001946B1 (fr)
EG (1) EG23684A (fr)
ES (1) ES2180922T3 (fr)
GB (1) GB9600847D0 (fr)
HK (1) HK1016473A1 (fr)
HU (1) HU225472B1 (fr)
IL (1) IL124913A0 (fr)
MX (1) MX9805713A (fr)
MY (1) MY127527A (fr)
NO (1) NO315689B1 (fr)
NZ (1) NZ326769A (fr)
OA (1) OA10812A (fr)
PE (1) PE35498A1 (fr)
PL (1) PL187291B1 (fr)
PT (1) PT874632E (fr)
SK (1) SK282132B6 (fr)
TR (1) TR199800954T2 (fr)
TW (1) TW434016B (fr)
UA (1) UA63897C2 (fr)
UY (2) UY24437A1 (fr)
WO (1) WO1997025990A1 (fr)
ZA (1) ZA97310B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
CA2103050A1 (fr) 1991-05-15 1992-11-16 Yung-Chi Cheng Dosage de precurseurs de medicaments metabolisables par le foie et utilisation therapeutique de ce dosage
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
HUP9901021A3 (en) 2000-08-28
GB9600847D0 (en) 1996-03-20
OA10812A (en) 2003-01-29
TW434016B (en) 2001-05-16
NZ326769A (en) 2000-05-26
BG63488B1 (bg) 2002-03-29
PE35498A1 (es) 1998-08-07
UY24556A1 (es) 2001-08-27
CN1132582C (zh) 2003-12-31
AP1114A (en) 2002-10-18
UY24437A1 (es) 1997-06-06
JP2000503311A (ja) 2000-03-21
IL124913A0 (en) 1999-01-26
BR9706982A (pt) 1999-07-20
AP747A (en) 1999-05-03
TR199800954T2 (xx) 1998-10-21
EG23684A (en) 2007-05-09
ATE220910T1 (de) 2002-08-15
DE69714215T2 (de) 2003-01-23
AP9801298A0 (en) 1998-09-30
CN1208350A (zh) 1999-02-17
CY2390B1 (en) 2004-09-10
CZ287205B6 (en) 2000-10-11
AU1541897A (en) 1997-08-11
AP9700911A0 (en) 1997-01-31
US6765007B1 (en) 2004-07-20
HK1016473A1 (en) 1999-11-05
PL187291B1 (pl) 2004-06-30
BG102638A (en) 1999-07-30
EA199800573A1 (ru) 1999-02-25
SK95698A3 (en) 1999-01-11
NO983259D0 (no) 1998-07-15
CZ225498A3 (cs) 1998-12-16
EP0874632B1 (fr) 2002-07-24
ES2180922T3 (es) 2003-02-16
KR19990077229A (ko) 1999-10-25
NO983259L (no) 1998-07-15
WO1997025990A1 (fr) 1997-07-24
DK0874632T3 (da) 2002-11-11
EP0874632A1 (fr) 1998-11-04
NO315689B1 (no) 2003-10-13
UA63897C2 (en) 2004-02-16
AR005456A1 (es) 1999-06-23
EA001946B1 (ru) 2001-10-22
JP4711360B2 (ja) 2011-06-29
ZA97310B (en) 1997-10-23
MX9805713A (es) 1998-10-31
AU713090B2 (en) 1999-11-25
HUP9901021A2 (hu) 1999-08-30
DZ2159A1 (fr) 2002-12-01
HU225472B1 (en) 2006-12-28
PL327922A1 (en) 1999-01-04
DE69714215D1 (de) 2002-08-29
PT874632E (pt) 2002-10-31
MY127527A (en) 2006-12-29
JP2009091362A (ja) 2009-04-30
KR100338829B1 (ko) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2019272064B2 (en) High dosage strength tablets of rucaparib
EP3417861B1 (fr) Composition pharmaceutique contenant un inhibiteur de janus kinase (jak) ou un sel pharmaceutiquement acceptable de celui-ci
RU2401109C2 (ru) Таблетированный препарат с замедленным высвобождением для вертиго
SK96497A3 (en) Valaciclovir tablet, preparation method thereof and their use
SK284049B6 (sk) Orálny prostriedok a spôsob jeho prípravy
JPH04224514A (ja) 薬物のタブレット組成物およびその製造法
JP2009091362A6 (ja) 高含量ファムシクロビル錠剤
JP2009091362A (ja) 高含量ファムシクロビル錠剤
US20080008751A1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
US20060147519A1 (en) Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
CN110037995B (zh) 一种稳定的盐酸帕罗西汀片剂及其制备方法
KR20180100869A (ko) 피르페니돈의 입자크기 조절에 따른 타정성이 개선된 약제학적 조성물 및 이의 제조방법
BG61242B2 (bg) Твърд фармацевтичен състав за орална употреба на база дапипразол
US6737419B2 (en) Benazepril hydrochloride tablet formulations
CA2240462C (fr) Comprimes a forte teneur en famciclovir
EP3372227A1 (fr) Formulation de comprimé d'adéfovir dipivoxil
EP1889629B1 (fr) Préparation stable contenant une combinaison d'une substance active sensible à l' humidité et d'une deuxième substance active et procédure de fabrication de la préparation.
JP3935539B2 (ja) フマル酸ケトチフェン含有医薬組成物
KR100561025B1 (ko) 직접 타정법에 의해 제조되며 보관안정성이 증진된 라미프릴 정제
CA2659814A1 (fr) Formulation stable comprenant une combinaison d'un medicament sensible a l'humidite et d'un second medicament et procedure de fabrication de celle-ci

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20170113